1. The IPO was priced at $17 per share, according to the report.
2. Evolent increased the number of shares in the offering from 10 million to 11.5 million.
3. The software company is selling all of the class A shares in the offering.
4. Evolent is now valued at approximately $950 million.
More articles on health IT:
5 top data breach trends for this year
3M releases ICD-10 translation tool
Plug-and-play in action at the Center for Medical Interoperability
